We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Robotic-assisted transrectal MRI-guided biopsy. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience.
- Authors
Vilanova, Joan C.; Pérez de Tudela, Anna; Puig, Josep; Hoogenboom, Martijn; Barceló, Joaquim; Planas, Montse; Sala, Sònia; Thió-Henestrosa, Santiago
- Abstract
Objectives: To evaluate the potential clinical and technical utility to manage in practice the use of a robotic MRI in-bore-targeted prostate biopsies in the current work-up of prostate cancer diagnosis. Methods: Thirty patients with a single cancer suspicious lesion interpreted on MRI using PI-RADSv2.1 category ≥ 3 underwent in-bore robotic transrectal MRI remote-controlled-guided biopsy. It was analyzed the technical success, clinical details, biopsy findings in correlation with the MRI examination, complications and cancer detection rate (CDR). Results: The overall CDR for any cancer was 73% (22/30). It was 86% (19/22) for significant tumors (Gleason score of more than 6 or maximum cancer core length greater than 3 mm for Gleason 6) and 77% (17/22) for tumors with Gleason > 6. CDR for biopsy-naïve patients was 89% (16/18) and 50% (6/12) for patients with prior negative transrectal ultrasound-guided biopsies. The CDR for PI-RADS > 3 was 92% (22/24). All the lesions (n = 30) were reachable with the robotic MRI device. A self-limited rectal hemorrhagic complication was reported. Conclusion: This initial data show that a robotic MRI-guided biopsy could be useful, efficient and feasible procedure in the new paradigm to diagnose significant prostate cancer in selected patients.
- Subjects
ENDORECTAL ultrasonography; CANCER diagnosis; PROSTATE cancer patients; ROBOTICS; BIOPSY; PROSTATE biopsy
- Publication
Abdominal Radiology, 2020, Vol 45, Issue 12, p4150
- ISSN
2366-004X
- Publication type
Article
- DOI
10.1007/s00261-020-02665-6